Higher Descent Data as a Homotopy Limit

We define the 2-groupoid of descent data assigned to a cosimplicial 2-groupoid and present it as the homotopy limit of the cosimplicial space gotten after applying the 2-nerve in each cosimplicial degree. This can be applied also to the case of $n$-groupoids thus providing an analogous presentation of "descent data" in higher dimensions.Comment: Appeared in JHR

Simulator for Microlens Planet Surveys

We summarize the status of a computer simulator for microlens planet surveys. The simulator generates synthetic light curves of microlensing events observed with specified networks of telescopes over specified periods of time. Particular attention is paid to models for sky brightness and seeing, calibrated by fitting to data from the OGLE survey and RoboNet observations in 2011. Time intervals during which events are observable are identified by accounting for positions of the Sun and the Moon, and other restrictions on telescope pointing. Simulated observations are then generated for an algorithm that adjusts target priorities in real time with the aim of maximizing planet detection zone area summed over all the available events. The exoplanet detection capability of observations was compared for several telescopes.Comment: Proc. IAU Symp. No. 293 "Formation, detection, and characterization of extrasolar habitable planets", ed. by N. Haghighipour. 4 pages, in pres

SuperWASP: Wide Angle Search for Planets

SuperWASP is a fully robotic, ultra-wide angle survey for planetary transits. Currently under construction, it will consist of 5 cameras, each monitoring a 9.5 x 9.5 deg field of view. The Torus mount and enclosure will be fully automated and linked to a built-in weather station. We aim to begin observations at the beginning of 2003.Comment: 4 pages, 1 figure, to be published in proceedings of "Scientific Frontiers in Research on Extrasolar Planets

Current Status of the SuperWASP Project

We present the current status of the SuperWASP project, a Wide Angle Search for Planets. SuperWASP consists of up to 8 individual cameras using ultra-wide field lenses backed by high-quality passively cooled CCDs. Each camera covers 7.8 x 7.8 sq degrees of sky, for nearly 500 sq degrees of sky coverage. SuperWASP I, located in LaPalma, is currently operational with 5 cameras and is conducting a photometric survey of a large numbers of stars in the magnitude range ~7 to 15. The collaboration has developed a custom-built reduction pipeline and aims to achieve better than 1 percent photometric precision. The pipeline will also produce well sampled light curves for all the stars in each field which will be used to detect: planetary transits, optical transients, and track Near-Earth Objects. Status of current observations, and expected rates of extrasolar planetary detections will be presented. The consortium members, institutions, and further details can be found on the web site at: http://www.superwasp.org.Comment: 3 pages, 2 figures, submitted to the Proceedings of the 13th Cool Stars Workshop, Ed. F. Favata, ESA-S

The first WASP public data release

The WASP (wide angle search for planets) project is an exoplanet transit survey that has been automatically taking wide field images since 2004. Two instruments, one in La Palma and the other in South Africa, continually monitor the night sky, building up light curves of millions of unique objects. These light curves are used to search for the characteristics of exoplanetary transits. This first public data release (DR1) of the WASP archive makes available all the light curve data and images from 2004 up to 2008 in both the Northern and Southern hemispheres. A web interface () to the data allows easy access over the Internet. The data set contains 3 631 972 raw images and 17 970 937 light curves. In total the light curves have 119 930 299 362 data points available between them

Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer

BACKGROUND: Men diagnosed with localised prostate cancer (LPC) face difficult choices between treatment options that can cause persistent problems with sexual, urinary and bowel function. Controlled trial evidence about the survival benefits of the full range of treatment alternatives is limited, and patients' views on the survival gains that might justify these problems have not been quantified. METHODS: A discrete choice experiment (DCE) was administered in a random subsample (n=357, stratified by treatment) of a population-based sample (n=1381) of men, recurrence-free 3 years after diagnosis of LPC, and 65 age-matched controls (without prostate cancer). Survival gains needed to justify persistent problems were estimated by substituting side effect and survival parameters from the DCE into an equation for compensating variation (adapted from welfare economics). RESULTS: Median (2.5, 97.5 centiles) survival benefits needed to justify severe erectile dysfunction and severe loss of libido were 4.0 (3.4, 4.6) and 5.0 (4.9, 5.2) months. These problems were common, particularly after androgen deprivation therapy (ADT): 40 and 41% overall (n=1381) and 88 and 78% in the ADT group (n=33). Urinary leakage (most prevalent after radical prostatectomy (n=839, mild 41%, severe 18%)) needed 4.2 (4.1, 4.3) and 27.7 (26.9, 28.5) months survival benefit, respectively. Mild bowel problems (most prevalent (30%) after external beam radiotherapy (n=106)) needed 6.2 (6.1, 6.4) months survival benefit. CONCLUSION: Emerging evidence about survival benefits can be assessed against these patient-based benchmarks. Considerable variation in trade-offs among individuals underlines the need to inform patients of long-term consequences and incorporate patient preferences into treatment decisions. © 2012 Cancer Research UK. All rights reserved

A note on the Mittag–Leffler condition for Bredon-modules

In this note we show the Bredon-analogue of a result by Emmanouil and Talelli, which gives a criterion when the homological and cohomological dimensions of a countable group $G$ agree. We also present some applications to groups of Bredon-homological dimension $1$.Comment: 10 page

Protocol for the development and validation procedure of the managing the link and strengthening transition from child to adult mental health care (MILESTONE) suite of measures

Background: Mental health disorders in the child and adolescent population are a pressing public health concern. Despite the high prevalence of psychopathology in this vulnerable population, the transition from Child and Adolescent Mental Health Services (CAMHS) to Adult Mental Health Services (AMHS) has many obstacles such as deficiencies in planning, organisational readiness and policy gaps. All these factors contribute to an inadequate and suboptimal transition process. A suite of measures is required that would allow young people to be assessed in a structured and standardised way to determine the on-going need for care and to improve communication across clinicians at CAMHS and AMHS. This will have the potential to reduce the overall health economic burden and could also improve the quality of life for patients travelling across the transition boundary. The MILESTONE (Managing the Link and Strengthening Transition from Child to Adult Mental Health Care) project aims to address the significant socioeconomic and societal challenge related to the transition process. This protocol paper describes the development of two MILESTONE transition-related measures: The Transition Readiness and Appropriateness Measure (TRAM), designed to be a decision-making aide for clinicians, and the Transition Related Outcome Measure (TROM), for examining the outcome of transition. Methods: The TRAM and TROM have been developed and were validated following the US FDA Guidance for Patient-reported Outcome Measures which follows an incremental stepwise framework. The study gathers information from service users, parents, families and mental health care professionals who have experience working with young people undergoing the transition process from eight European countries. Discussion: There is an urgent need for comprehensive measures that can assess transition across the CAMHS/AMHS boundary. This study protocol describes the process of development of two new transition measures: the TRAM and TROM. The TRAM has the potential to nurture better transitions as the findings can be summarised and provided to clinicians as a clinician-decision making support tool for identifying cases who need to transition and the TROM can be used to examine the outcomes of the transition process. Trial registration: MILESTONE study registration: ISRCTN83240263 Registered 23-July-2015 - ClinicalTrials.gov NCT03013595 Registered 6 January 2017